Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs Intensive Training for HIIP in Type 2 Diabetes
NCT00099515Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2004
- Countries
- 4
01
Overview
Phase 2, randomised, open-label trial of AIR Inhaled Insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: 2-hour postprandial glucose excursion of self-monitored blood glucose at 4 weeks. Started Nov 2004; status: completed.
02
Drugs
AIR Inhaled Insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00099515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099515.